Jürgen Schauber

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi request reprint [Cathelicidin LL-37. A central factor in the pathogenesis of inflammatory dermatoses?]
    J Schauber
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilians Universitat Munchen, Frauenlobstrasse 9 11, 80337 München
    Hautarzt 59:72-4. 2008
  2. pmc The vitamin D pathway: a new target for control of the skin's immune response?
    Jürgen Schauber
    Department of Dermatology and Allergology, Ludwig Maximilians University, Munich, Germany
    Exp Dermatol 17:633-9. 2008
  3. ncbi request reprint [Topical therapy of perianal eczema]
    J Schauber
    Klinik für Dermatologie und Allergologie, Ludwig Maximilians Universitat Munchen, Munchen, Deutschland
    Hautarzt 61:33-8. 2010
  4. doi request reprint Control of cutaneous antimicrobial peptides by vitamin D3
    Yvonne Dombrowski
    Department of Dermatology and Allergy, Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilian University, Frauenlobstr 9 11, Munich, Germany
    Arch Dermatol Res 302:401-8. 2010
  5. pmc Vitamin d, the cutaneous barrier, antimicrobial peptides and allergies: is there a link?
    Elisabeth Roider
    Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
    Allergy Asthma Immunol Res 5:119-28. 2013
  6. pmc Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis
    Mark Peric
    Department of Dermatology and Allergology, Ludwig Maximilians University, Munich, Germany
    PLoS ONE 4:e6340. 2009
  7. pmc Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease
    Markus Reinholz
    Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
    Ann Dermatol 24:126-35. 2012
  8. doi request reprint [Current insights into the pathophysiology of rosacea]
    J Schauber
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwigs Maximilians Universität München, Frauenlobstr 9 11, 80337, Munchen, Deutschland
    Hautarzt 64:481-8. 2013
  9. doi request reprint [Antimicrobial peptides, Vitamin D₃ and more. How rosacea may develop]
    J Schauber
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilians Universitat Munchen, Frauenlobstr 9 11, 80337 München
    Hautarzt 62:815-9. 2011
  10. ncbi request reprint Topical treatment of perianal eczema with tacrolimus 0.1%
    J Schauber
    Department of Dermatology, Ludwig Maximilians University, Munich, Germany
    Br J Dermatol 161:1384-6. 2009

Collaborators

Detail Information

Publications22

  1. ncbi request reprint [Cathelicidin LL-37. A central factor in the pathogenesis of inflammatory dermatoses?]
    J Schauber
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilians Universitat Munchen, Frauenlobstrasse 9 11, 80337 München
    Hautarzt 59:72-4. 2008
    ..These studies demonstrate the role of cathelicidin as a central factor in the pathogenesis of cutaneous inflammation. Therapies targeting cathelicidin expression and function could lead to new treatments for these diseases...
  2. pmc The vitamin D pathway: a new target for control of the skin's immune response?
    Jürgen Schauber
    Department of Dermatology and Allergology, Ludwig Maximilians University, Munich, Germany
    Exp Dermatol 17:633-9. 2008
    ..Therapies targeting the vitamin D3 pathway and thereby cathelicidin may provide new treatment modalities in the management of infectious and inflammatory skin diseases...
  3. ncbi request reprint [Topical therapy of perianal eczema]
    J Schauber
    Klinik für Dermatologie und Allergologie, Ludwig Maximilians Universitat Munchen, Munchen, Deutschland
    Hautarzt 61:33-8. 2010
    ..Patients should avoid topical irritants and potential contact allergens. Perianal eczema resistant to therapy should be further evaluated by histopathological workup to exclude precancerous or malignant skin disease...
  4. doi request reprint Control of cutaneous antimicrobial peptides by vitamin D3
    Yvonne Dombrowski
    Department of Dermatology and Allergy, Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilian University, Frauenlobstr 9 11, Munich, Germany
    Arch Dermatol Res 302:401-8. 2010
    ..Therapies targeting vitamin D3 signaling may provide new approaches for infectious and inflammatory skin diseases by affecting both innate and adaptive immune functions...
  5. pmc Vitamin d, the cutaneous barrier, antimicrobial peptides and allergies: is there a link?
    Elisabeth Roider
    Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
    Allergy Asthma Immunol Res 5:119-28. 2013
    ..In this review the role of vitamin D and the AMP cathelicidin in the pathogenesis of atopic diseases with impaired barrier function will be discussed...
  6. pmc Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis
    Mark Peric
    Department of Dermatology and Allergology, Ludwig Maximilians University, Munich, Germany
    PLoS ONE 4:e6340. 2009
    ..Balancing AMP "alarmin" expression might be a novel goal in treatment of chronic inflammatory skin diseases...
  7. pmc Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease
    Markus Reinholz
    Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
    Ann Dermatol 24:126-35. 2012
    ..As cathelicidin LL-37 might also serve as a future treatment target potential novel treatment strategies for those diseases will be discussed...
  8. doi request reprint [Current insights into the pathophysiology of rosacea]
    J Schauber
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwigs Maximilians Universität München, Frauenlobstr 9 11, 80337, Munchen, Deutschland
    Hautarzt 64:481-8. 2013
    ..A disturbed chemokine and cytokine network further contributes to disease progression. This current review highlights some of the recent findings in rosacea pathophysiology and points out novel targets for therapeutic intervention. ..
  9. doi request reprint [Antimicrobial peptides, Vitamin D₃ and more. How rosacea may develop]
    J Schauber
    Klinik und Poliklinik fur Dermatologie und Allergologie, Ludwig Maximilians Universitat Munchen, Frauenlobstr 9 11, 80337 München
    Hautarzt 62:815-9. 2011
    ..These data increase our understanding of the pathogenesis and therapy of rosacea. Also, these insights might uncover novel targets for innovative therapies of this common, stigmatizing skin disease...
  10. ncbi request reprint Topical treatment of perianal eczema with tacrolimus 0.1%
    J Schauber
    Department of Dermatology, Ludwig Maximilians University, Munich, Germany
    Br J Dermatol 161:1384-6. 2009
    ..Topical calcineurin inhibitors such as tacrolimus (FK506) ameliorate cutaneous inflammation and associated pruritus in an array of inflammatory dermatoses...
  11. doi request reprint VDR and MEK-ERK dependent induction of the antimicrobial peptide cathelicidin in keratinocytes by lithocholic acid
    Mark Peric
    Department of Dermatology and Allergy, Ludwig Maximilians University, Munich, Germany
    Mol Immunol 46:3183-7. 2009
    ..Based on these observations LCA-like molecules targeting cathelicidin could be designed for the treatment of cutaneous diseases that are characterized by disturbed cathelicidin expression...
  12. ncbi request reprint Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis
    Zuzana Hegyi
    Department of Dermatology and Allergology, Ludwig Maximilian University, Munich, Germany
    J Invest Dermatol 132:1416-24. 2012
    ..Thus, targeting the S100-amplification loop could be a beneficial anti-inflammatory approach in psoriasis and other inflammatory skin diseases...
  13. pmc IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes
    Mark Peric
    Department of Dermatology and Allergology, Ludwig Maximilians University, Munich, Germany
    J Immunol 181:8504-12. 2008
    ..Therapy targeting this cathelicidin-regulating system might be beneficial in patients suffering from psoriasis...
  14. ncbi request reprint Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis
    Yvonne Dombrowski
    Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
    Exp Dermatol 21:327-30. 2012
    ..Hence, cathelicidin LL-37 shows contrasting roles in skin inflammation in psoriasis and might serve as a target for novel therapies for this chronic skin disease...
  15. ncbi request reprint Antimicrobial peptides and the skin immune defense system
    Jürgen Schauber
    Department of Dermatology and Allergology, Ludwig Maximilians University, Munich, Germany
    J Allergy Clin Immunol 124:R13-8. 2009
    ..Therapies targeting control of cathelicidin and other AMPs might provide new approaches in the management of infectious and inflammatory skin diseases...
  16. pmc Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions
    Yvonne Dombrowski
    Department of Dermatology and Allergy, Ludwig Maximilian University, 80337 Munich, Germany
    Sci Transl Med 3:82ra38. 2011
    ..Thus, our data reveal a link between the AIM2 inflammasome, cathelicidin LL-37, and autoinflammation in psoriasis, providing new potential targets for the treatment of this chronic skin disease...
  17. pmc Antimicrobial peptides and the skin immune defense system
    Jürgen Schauber
    Department of Dermatology and Allergology, Ludwig Maximilians University, Munich, Germany
    J Allergy Clin Immunol 122:261-6. 2008
    ..Therapies targeting control of cathelicidin and other AMPs might provide new approaches in the management of infectious and inflammatory skin diseases...
  18. ncbi request reprint Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis--a possible target for novel therapies?
    Miriam Canavese
    Department of Dermatology and Allergy, Ludwig Maximilian University, 80337 Munich, Germany
    J Dermatol Sci 58:171-6. 2010
    ..Furthermore, current reports on treatments directed against VEGF or its receptors and their potential as future therapy for psoriasis are discussed...
  19. ncbi request reprint Treatment of striae distensae using an ablative Erbium: YAG fractional laser versus a 585-nm pulsed-dye laser
    Gerd G Gauglitz
    Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
    J Cosmet Laser Ther 16:117-9. 2014
    ..Here, we report on the effect of an ablative Erbium:YAG fractional laser in two cases of axillary SD in comparison with a 585-nm PDL. ..
  20. ncbi request reprint Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
    Cornelia Tillack
    Department of Medicine II Grosshadern, Ludwig Maximilians University LMU, Munich, Germany
    Gut 63:567-77. 2014
    ..We analysed incidence, predictors, histological features and specific treatment options of anti-tumour necrosis factor α (TNF-α) antibody-induced psoriasiform skin lesions in patients with inflammatory bowel diseases (IBD)...
  21. ncbi request reprint Face-to-face with anti-inflammatory therapy for rosacea
    Suzanna Salzer
    Department of Dermatology and Allergy, Ludwig Maximilian University, Munich, Germany
    Exp Dermatol 23:379-81. 2014
    ....
  22. doi request reprint Innate immunity in atopic dermatitis
    Andreas Wollenberg
    Department of Dermatology and Allergy, Ludwig Maximilian University of Munich, Germany
    Clin Rev Allergy Immunol 41:272-81. 2011
    ..Future therapeutic approaches to AD may include enhancement of impaired innate in addition to downregulation of dysfunctional adaptive immunity...